BCMO

World Biopharmaceutical Contract Manufacturing Organization (BCMO) Market Research Report 2022: Focus on Growth Factors - Biotechnology, Biosimilars, & Cell and Gene Therapies - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 12, 2022
Biotechnology, Pharmaceutical, Health, Segment, Biotechnology, Commercial, Industry, BCMO, Fine chemical, EU

The "Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022" report has been added to ResearchAndMarkets.com's offering.
  • This report, Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022, describes and discusses the global contract manufacturing markets, specifically focusing on the production of biotech (large molecule) products including extensive coverage of the biotechnology segment of the global BCMO industry.
  • Further, this report examines third party manufacturing of potential and commercialized prescription drug products throughout the world.
  • The report contains the following market information:
    BCMO Market by Segment (Clinical Manufacturing, Commercial Manufacturing) and More

Fragmented BCMO Market Pressured by Economic and Pharmaceutical Industry Factors

Retrieved on: 
Tuesday, October 4, 2022
Environment, Industry, BCMO, Budget, Investment, Pressure, Patent, Wuxi, Marketing, Catalent, Uncertainty, Pharmaceutical industry, Fine chemical, Generic drug, Health insurance

ARLINGTON, Va., Oct. 4, 2022 /PRNewswire-PRWeb/ -- The global biopharmaceutical contract manufacturing organization (BCMO) industry is highly fragmented, with 40 BCMOs/CDMOs accounting for roughly one quarter of the industry's revenues and the remainder comprised of a large number of smaller players. Based upon 2021 figures, Catalent led the overall market with estimated BCMO sales of $2.2 billion It was followed closely by Cytiva with $2.0 billion While these market leaders are active in most of the geographic market segments, smaller players tend to focus on a few regions, particularly the U.S. and/or Western Europe. Besides market leaders, companies of interest include Dr. Reddy's as well as WuXi AppTec, Pfizer CentreOne, Baxter. This is according to Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022, Kalorama's latest report on the sector.

Key Points: 
  • Besides market leaders, companies of interest include Dr. Reddy's as well as WuXi AppTec, Pfizer CentreOne, Baxter.
  • This is according to Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022 , Kalorama's latest report on the sector.
  • Additionally, ongoing economic challenges will further pressure the industry, making drug maker financial performance even more important and tightening access to capital for smaller players.
  • While all of these factors are important, the impact of the economic pressures cannot be overstated since many drug makers are publicly traded and financial pressures directly impact their budgets.